Trident Lifeline Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹33.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 32.49 per cent from ₹49.95 crore. This corresponds to a year-on-year *(YoY) growth of 42.82 per cent.
Operating Profit
Operating Profit stands at ₹8.52 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.40 per cent from ₹10.98 crore. This corresponds to a year-on-year *(YoY) growth of 64.80 per cent.
PBDT
PBDT stands at ₹8.23 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.55 per cent from ₹11.85 crore. This corresponds to a year-on-year *(YoY) growth of 52.69 per cent.
Profit Before Tax
Profit Before Tax stands at ₹6.61 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.76 per cent from ₹10.62 crore. This corresponds to a year-on-year *(YoY) growth of 68.19 per cent.
Net Profit
Net Profit stands at ₹5.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 25.44 per cent from ₹6.80 crore. This represents a 82.37 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Trident Lifeline Ltd Earnings
- YOY
- QOQ
Trident Lifeline Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Trident Lifeline Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Trident Lifeline Ltd Financial Reports
Trident Lifeline Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Trident Lifeline | 17.43% | 21.87% | 35.76% | 49.29% | 50.26% | 24.27% |
| Aptus Pharma | 1.99% | 1.95% | 21.61% | 57.47% | 168.31% | 962.02% |
| Albert David | -0.86% | -1.90% | -5.25% | 16.99% | 30.99% | 5.13% |
| Haleos Labs Limited | -0.83% | -2.66% | -2.84% | 12.03% | 16.96% | 22.32% |
| Jenburkt Pharma | 2.01% | 0.24% | -3.96% | -11.52% | 4.14% | -5.61% |
| Medicamen Biotec | -4.62% | -8.30% | 34.56% | 30.54% | 32.60% | -5.70% |
| Astonea Labs | -2.82% | 9.89% | 23.92% | 32.60% | 124.43% | 99.65% |
Company Info
Company Information
Chairman/ED & CEO : Hardik J Desai
ED / MD / Promoter : Shravan Harikrishna Patel
Non-Exec & Non-Independent Dir : Maniya H Desai
Independent Non Exe. Director : Mishal Shailesh Patel
Independent Non Exe. Director : Falguni Bhavesh Jariwala
Whole-time Director : Rupaben Chetanbhai Jariwala
Director & CFO : ASHISH ANANDSINGH BAFNA
Company Sec. & Compli. Officer : Nikita Sharma